[go: up one dir, main page]

PE20110799A1 - Combinacion farmaceutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y paracetamol - Google Patents

Combinacion farmaceutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y paracetamol

Info

Publication number
PE20110799A1
PE20110799A1 PE2011000208A PE2011000208A PE20110799A1 PE 20110799 A1 PE20110799 A1 PE 20110799A1 PE 2011000208 A PE2011000208 A PE 2011000208A PE 2011000208 A PE2011000208 A PE 2011000208A PE 20110799 A1 PE20110799 A1 PE 20110799A1
Authority
PE
Peru
Prior art keywords
dimethylaminomethyl
diol
phenyl
metoxy
paracetamol
Prior art date
Application number
PE2011000208A
Other languages
English (en)
Inventor
Petra Bloms-Funke
Klaus Schiene
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40328601&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20110799(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20110799A1 publication Critical patent/PE20110799A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

REFERIDA A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) UN COMPONENTE DE 6-DIMETILAMINOMETIL-1-(3-METOXI-FENIL)-CICLOHEXANO-1,3-DIOL, PREFERENTEMENTE (1RS,3RS,6RS)-6-DIMETILAMINOMETIL-1-(3-METOXI-FENIL)-CICLOHEXANO-1,3-DIOL; B) PARACETAMOL O DERIVADO DEL MISMO SELECCIONADO DE PROPACETAMOL, FENIDINA. DICHA COMPOSICION ES APROPIADA PARA LA ADMINISTRACION ORAL, INTRAVENOSA, INTRAPERITONEAL, INTRADERMAL, INTRAMUSCULAR, TRANSMUCOSAL, ENTRE OTROS, SIENDO UTILES EN EL TRATAMIENTO DE OSTEOARTRITIS Y DOLOR INFLAMATORIO, DOLOR NEUROPATICO, DOLOR CRONICO, DOLOR VISCERAL, DOLOR DE MIGRANA Y DOLOR CAUSADO POR CANCER
PE2011000208A 2008-09-05 2009-09-04 Combinacion farmaceutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y paracetamol PE20110799A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08015621 2008-09-05

Publications (1)

Publication Number Publication Date
PE20110799A1 true PE20110799A1 (es) 2011-11-10

Family

ID=40328601

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2011000208A PE20110799A1 (es) 2008-09-05 2009-09-04 Combinacion farmaceutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y paracetamol

Country Status (19)

Country Link
US (1) US20100069501A1 (es)
EP (1) EP2331087A1 (es)
JP (1) JP2012501985A (es)
KR (1) KR20110059634A (es)
CN (1) CN102202660A (es)
AR (1) AR073277A1 (es)
AU (1) AU2009289824A1 (es)
BR (1) BRPI0918566A2 (es)
CA (1) CA2735855A1 (es)
CL (1) CL2011000387A1 (es)
CO (1) CO6341552A2 (es)
EC (1) ECSP11010876A (es)
IL (1) IL211395A0 (es)
MX (1) MX2011002430A (es)
NZ (1) NZ591419A (es)
PE (1) PE20110799A1 (es)
RU (1) RU2011112443A (es)
WO (1) WO2010025930A1 (es)
ZA (1) ZA201101669B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9855286B2 (en) 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US20130310435A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0566709T5 (da) * 1991-09-06 2009-05-18 Ortho Mcneil Janssen Pharm Præparat indeholdende et tramadolmateriale og acetaminophen og anvendelse deraf
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
WO2000051685A1 (en) * 1999-03-01 2000-09-08 Ortho-Mcneil Pharmaceutical, Inc. Composition comprising a tramadol material and a selective cox-2 inhibitor drug
DK3241550T3 (da) * 2002-11-22 2020-08-24 Gruenenthal Gmbh Anvendelse af (1r,2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol til behandling af inflammatoriske smerter

Also Published As

Publication number Publication date
NZ591419A (en) 2011-11-25
ECSP11010876A (es) 2011-04-29
RU2011112443A (ru) 2012-10-10
US20100069501A1 (en) 2010-03-18
WO2010025930A1 (en) 2010-03-11
CL2011000387A1 (es) 2011-06-17
EP2331087A1 (en) 2011-06-15
CA2735855A1 (en) 2010-03-11
IL211395A0 (en) 2011-05-31
KR20110059634A (ko) 2011-06-02
AU2009289824A1 (en) 2010-03-11
BRPI0918566A2 (pt) 2016-02-10
MX2011002430A (es) 2011-04-05
ZA201101669B (en) 2011-11-30
CO6341552A2 (es) 2011-11-21
CN102202660A (zh) 2011-09-28
AR073277A1 (es) 2010-10-28
JP2012501985A (ja) 2012-01-26

Similar Documents

Publication Publication Date Title
CO2023018231A2 (es) Restos de administración terapéutica novedosos y usos de estos
CL2017003138A1 (es) Compuesto derivado triciclico, metodo de preparacion del mismo y composicion farmaceutica que lo comprende.
MX2012003563A (es) Agente desinfectante que comprende eugenol, terpineol y timol.
CO2018005361A2 (es) Formulaciones inyectables de toxina botulínica y sus métodos de uso que poseen efecto terapéutico o cosmético de larga duración
MX339555B (es) Uso de los inhibidores de la fosfodiesterasa 7 para el tratamiento de trastornos del movimiento.
SV2017005461A (es) Benzamidas sustituidas con 1,3-tiazol-2-ilo
CU20070203A7 (es) Composición farmacéutica que comprende una difenilurea sustituida con omega-carboxiarilo para el tratamiento del cáncer
UY33480A (es) Compuestos terapeuticos, composicion farmaceutica que lo comprende, metodo de tratamiento y su uso para la manufactura de un medicamento.
CL2013000063A1 (es) Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion.
UY31205A1 (es) Composiciones de tabletas de desintegracion oral de lamotrigina
UY33700A (es) ?combinaciones farmacéuticas para el tratamiento de trastornos metabólicos?.
CR11510A (es) Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer
CO6781465A2 (es) Composición farmacéutica, métodos de tratamiento y usos de la misma
MX373763B (es) Uso de una composición de combinación de acamprosato y baclofeno de liberación sostenida, para el tratamiento de esclerosis lateral amiotrófica.
NZ715686A (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
CR11418A (es) Trans-clomifeno para el sindrome metabolico
MX2012005013A (es) Pterostilbeno (peter) para su uso en la prevencion y/el tratamiento de enfermedades, daños o lesiones de la piel.
MX354123B (es) Composición antiséptica oral para tratamiento de mucositis oral.
BR112017001093A2 (pt) formulação aquosa compreendendo paracetamol e ibuprofeno
MX2023006751A (es) Nuevo derivado de camptotecina, composicion que comprende el mismo y su uso.
AR090999A1 (es) Combinaciones farmaceuticas para el tratamiento de trastornos metabolicos
PE20110799A1 (es) Combinacion farmaceutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y paracetamol
CL2011001363A1 (es) Proceso para la preparacion de un compuesto derivado de etorfina; compuesto derivado de etorfina; composicion farmaceutica que lo comprende; uso del compuesto como analgesico en el tratamiento del dolor.
CO6280474A2 (es) Composicion farmaceutica para el tratamiento de la eyaculacion precoz
CL2012001671A1 (es) Compuestos derivados de (metilsulfonil)-etil-bencenoisoindolina; composicion farmaceutica que los comprende, uso en el tratamiento del cancer, dolor, trastornos del snc, enfermedades dermatologicas, entre otras.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal